Hsinchu County, Taiwan

Yi-Chia Lin



Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yi-Chia Lin: Innovator in Hepatitis B Therapeutic Vaccines

Introduction

Yi-Chia Lin is a prominent inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic vaccines for hepatitis B. His innovative work has the potential to impact public health positively.

Latest Patents

Yi-Chia Lin holds a patent for a hepatitis B therapeutic vaccine. The patent describes a fusion protein designed for use as a therapeutic vaccine against hepatitis B. This fusion protein includes an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a protein transduction domain, and an antigen that comprises a hepatitis B virus X protein deletion mutant. The protein transduction domain is a fusion polypeptide that consists of a T cell sensitizing signal-transducing peptide, a linker, and a translocation peptide. The APC-binding domain or the CD91 receptor-binding domain is positioned at the N-terminus of the fusion protein, while the antigen is located at the C-terminus of the protein transduction domain. This innovative approach aims to enhance the efficacy of hepatitis B vaccines.

Career Highlights

Yi-Chia Lin is associated with Thevax Genetics Vaccine Co., Ltd., where he continues to advance his research and development efforts. His work in the field of therapeutic vaccines has garnered attention and recognition within the scientific community. He has demonstrated a commitment to improving vaccine technology and addressing global health challenges.

Collaborations

Some of Yi-Chia Lin's notable coworkers include Chia-Mao Wu and Jiun-Ming Wu. Their collaborative efforts contribute to the ongoing research and development of innovative vaccine solutions.

Conclusion

Yi-Chia Lin's contributions to the field of hepatitis B therapeutic vaccines exemplify the importance of innovation in biotechnology. His work not only showcases his expertise but also highlights the potential for advancements in public health through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…